These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 35085210

  • 1. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2021 Nov 15; 63(1637):177-184. PubMed ID: 35085210
    [No Abstract] [Full Text] [Related]

  • 2. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2018 Jul 30; 60(1552):123-128. PubMed ID: 30044766
    [No Abstract] [Full Text] [Related]

  • 3. Expanded Table: Some biologic drugs and JAK inhibitors for rheumatoid arthritis.
    Med Lett Drugs Ther; 2021 Nov 15; 63(1637):e187-e189. PubMed ID: 35085212
    [No Abstract] [Full Text] [Related]

  • 4. Drugs for psoriatic arthritis.
    Med Lett Drugs Ther; 2019 Dec 30; 61(1588):203-210. PubMed ID: 31999665
    [No Abstract] [Full Text] [Related]

  • 5. Expanded table: some biologic agents and JAK inhibitors for RA.
    Med Lett Drugs Ther; 2018 Jul 30; 60(1552):e130-e134. PubMed ID: 30044768
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expanded Table: Some conventional DMARDs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2021 Nov 15; 63(1637):e185-e186. PubMed ID: 35085211
    [No Abstract] [Full Text] [Related]

  • 8. Expanded table: Some drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2023 Jul 10; 65(1680):e115-e119. PubMed ID: 37418332
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
    Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D.
    Ann Rheum Dis; 2020 Jun 10; 79(6):685-699. PubMed ID: 31969328
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
    Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.
    Ann Rheum Dis; 2017 Jun 10; 76(6):960-977. PubMed ID: 28264816
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2018 Jul 02; 60(1550):107-114. PubMed ID: 30036352
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
    Smolen JS, Landewé RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, Caporali R, Edwards CJ, Hyrich KL, Pope JE, de Souza S, Stamm TA, Takeuchi T, Verschueren P, Winthrop KL, Balsa A, Bathon JM, Buch MH, Burmester GR, Buttgereit F, Cardiel MH, Chatzidionysiou K, Codreanu C, Cutolo M, den Broeder AA, El Aoufy K, Finckh A, Fonseca JE, Gottenberg JE, Haavardsholm EA, Iagnocco A, Lauper K, Li Z, McInnes IB, Mysler EF, Nash P, Poor G, Ristic GG, Rivellese F, Rubbert-Roth A, Schulze-Koops H, Stoilov N, Strangfeld A, van der Helm-van Mil A, van Duuren E, Vliet Vlieland TPM, Westhovens R, van der Heijde D.
    Ann Rheum Dis; 2023 Jan 02; 82(1):3-18. PubMed ID: 36357155
    [Abstract] [Full Text] [Related]

  • 18. Drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2023 Jul 10; 65(1680):105-112. PubMed ID: 37418329
    [No Abstract] [Full Text] [Related]

  • 19. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
    Li N, Betts KA, Messali AJ, Skup M, Garg V.
    Clin Ther; 2017 Aug 10; 39(8):1618-1627. PubMed ID: 28729087
    [Abstract] [Full Text] [Related]

  • 20. Proposal for a new nomenclature of disease-modifying antirheumatic drugs.
    Smolen JS, van der Heijde D, Machold KP, Aletaha D, Landewé R.
    Ann Rheum Dis; 2014 Jan 10; 73(1):3-5. PubMed ID: 24072562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.